IT1250411B - Oligopeptidi eterociclici dotati di attivita' antitumorale - Google Patents

Oligopeptidi eterociclici dotati di attivita' antitumorale

Info

Publication number
IT1250411B
IT1250411B ITMI910572A ITMI910572A IT1250411B IT 1250411 B IT1250411 B IT 1250411B IT MI910572 A ITMI910572 A IT MI910572A IT MI910572 A ITMI910572 A IT MI910572A IT 1250411 B IT1250411 B IT 1250411B
Authority
IT
Italy
Prior art keywords
hydrogen
formula
previously defined
heterocyclic
group
Prior art date
Application number
ITMI910572A
Other languages
English (en)
Inventor
Nicola Mongelli
Alessio Roberto D
Maria Grandi
Federico Spreafico
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI910572A0 publication Critical patent/ITMI910572A0/it
Publication of ITMI910572A1 publication Critical patent/ITMI910572A1/it
Application granted granted Critical
Publication of IT1250411B publication Critical patent/IT1250411B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invenzione si riferisce a derivati di oligopeptidi eterociclici con attività citostatica di formula: (FORMULA I) in cui A è idrogeno; -NHCOR1 in cui R1 è un gruppo acrilico sostituito in posizione 2 con alogeno, ossiranile non sostituito o sostituito in posizione 2 o 3 con metile, aziridinile, ciclopropile, 4 - [N, N - bis - (2 - cloroetil) amino] fenile, un chetone aliciclico ? ? - insaturo oppure un lattone;(FORMULA) in cui R2 e R3 hanno entrambi lo stesso significato di gruppo alchile C2 - C4 sostituito in posizione 2 con alogeno o con un gruppo - OSO2R4, in cui R4 è alchile C2 -C4 oppure un gruppo fenile, oppure uno di R2 e R3 è idrogeno e l'altro ha il significato precedentemente definito;B è idrogeno ; - (CH2) NHCOR1, in cui R1 è quello precedentemente definito ed m ha il valore zero oppure è un numero intero da 1 a 3;purchè quando A è idrogeno B sia diverso da idrogeno, e quando A ha gli altri significati come precedentemente definiti ad eccezione di idrogeno, B sia soltanto idrogeno; Z e Z' sono ciascuno, indipendentemente, - CH= oppure - CH=CH-; X ed X' sono ciascuno, indipendentemente, N, O oppure S; e n è zero o 1; e loro esomeri e sali farmaceuticamente accettabili, e metodo e intermedi per il loro ottenimento.
ITMI910572A 1990-03-12 1991-03-05 Oligopeptidi eterociclici dotati di attivita' antitumorale IT1250411B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9005529A GB2241950B (en) 1990-03-12 1990-03-12 Heterocyclic oligopeptides endowed with antitumor activity

Publications (3)

Publication Number Publication Date
ITMI910572A0 ITMI910572A0 (it) 1991-03-05
ITMI910572A1 ITMI910572A1 (it) 1991-09-13
IT1250411B true IT1250411B (it) 1995-04-07

Family

ID=10672473

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910572A IT1250411B (it) 1990-03-12 1991-03-05 Oligopeptidi eterociclici dotati di attivita' antitumorale

Country Status (4)

Country Link
JP (1) JPH05148227A (it)
DE (1) DE4106860A1 (it)
GB (1) GB2241950B (it)
IT (1) IT1250411B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511562A (ja) * 2002-12-20 2006-04-06 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系疾患の処置のための置換２，５−ジアミドインドール類の使用
WO2016025692A1 (en) * 2014-08-13 2016-02-18 The Scripps Research Institute Treatment of c9ftd/als by targeting rna expanded repeat sequences

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521471A (en) * 1974-06-05 1978-08-16 Randall & Son Ltd J Token-deposit locks

Also Published As

Publication number Publication date
DE4106860A1 (de) 1991-09-19
ITMI910572A0 (it) 1991-03-05
JPH05148227A (ja) 1993-06-15
GB2241950A (en) 1991-09-18
GB2241950B (en) 1993-05-12
ITMI910572A1 (it) 1991-09-13
GB9005529D0 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
PT628311E (pt) Derivado de xantina com actividade antidepressiva
FI970317A0 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
NL300202I1 (nl) Nucleotide-analogen.
SE8900192D0 (sv) Dideoxididehydrokarbocykliska nukleosider
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
EP0125803A3 (en) Pharmaceutically active dihydropyridines
ZA792522B (en) Imidazole derivatives,process for their preparation and pharmaceutical preparations containing them
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
NO20011722L (no) 2,3-disubstituerte pyridinderivater, fremgangsmåte for fremstilling derav, preparater inneholdende disse, ogmellomprodukter derfor
DK118083D0 (da) Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler
NO890440D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
IT1250411B (it) Oligopeptidi eterociclici dotati di attivita' antitumorale
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
NO944577L (no) Hemming av effekten av amyloidogene proteiner
ATE275133T1 (de) 1,2-dihydro-2-oxochinolin-derivate
FR2618435B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
BR8103553A (pt) Derivados de imidazol preparacao farmaceutica processo para a fabricacao dos ditos derivados e uso dos mesmos
RU93033697A (ru) Производные 2-амино-n-[[[4-(аминокарбонил) пиримидин-2-ил]амино] алкил] пиримидин-4-карбоксамида, способ их получения и фармацевтическая композиция на их основе
FR2751655B1 (fr) Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations
AU6426386A (en) Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them
DE60021109D1 (de) Amycomycin, verfahren zu dessen herstellung und seine verwendung als arzneimittel
JPS5262285A (en) Preparation of n1 2'-ethoxy) furanidyl uracil derivatives

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970310